Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99)

Paediatric and Perinatal Epidemiology

Volumn 20, Issue 1, 2006, Pages 59-66

  Foucan, Lydia ^a,b   Ekouevi, Didier ^a   Etienne Julan, Maryse ^c   Salmi, L Rachid ^d   Diara, Jean Pierre ^b  

^a Département d'Information Médicale et de Santé Publique   (Guadeloupe)

^b CHU de Pointe a Pitre   (Guadeloupe)

^c UMR S 458 INSERM UAG   (Guadeloupe)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Acute chest syndrome; Dactylitis; Death; Sickle cell anaemia; Stroke; Survival

Indexed keywords

HEMOGLOBIN S;

ACUTE CHEST SYNDROME; ACUTE SPLEEN SEQUESTRATION; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HAND FOOT SYNDROME; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INFANT; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MALE; MEDICAL RECORD; ONSET AGE; PROGNOSIS; RISK ASSESSMENT; SICKLE CELL ANEMIA; SPLEEN DISEASE; STROKE; SURVIVAL RATE;

AGE OF ONSET; ANEMIA, SICKLE CELL; CEREBROVASCULAR ACCIDENT; CHEST PAIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; ERYTHEMA; FEMALE; FOOT; GUADELOUPE; HAND; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; SYNDROME;

EID: 33645131492     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2006.00692.x     Document Type: Article

References (28)

1. Platt OS Brambilla DJ Rosse WF Milner PF Castro O Steinberg MH et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death [see comments] New England Journal of Medicine 1994 330 1639 1644
2. Vichinsky EP Styles LA Colangelo LH Wright EC Castro O Nickerson B Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease Blood 1997 89 1787 1792
3. Castro O Brambilla DJ Thorington B Reindorf CA Scott RB Gillette P et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease Blood 1994 84 643 649
4. Thomas PW Higgs DR Serjeant GR Benign clinical course in homozygous sickle cell disease: a search for predictors Journal of Clinical Epidemiology 1997 50 121 126
5. Lee A Thomas P Cupidore L Serjeant B Serjeant G Improved survival in homozygous sickle cell disease: lessons from a cohort study British Medical Journal 1995 311 1600 1602
6. Serjeant GR Natural history and determinants of clinical severity of sickle cell disease Current Opinion in Hematology 1995 2 103 108
7. Wierenga KJ Hambleton IR Lewis NA Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study Lancet 2001 357 680 683
8. Le Turdu-Chicot C Foucan L Etienne-Julan M Leborgne-Samuel Y Fanhan R Berchel C Analysis of hospitalization of adult sickle-cell patients in Guadeloupe Revue de Médecine Interne 2000 21 24 29
9. Romana M Diara JP Doumbo L Muralitharan S Ramasawmy R Keclard L et al. Angiotensinogen gene associated polymorphisms and risk of stroke in sickle cell anemia: additional data supporting an association American Journal of Hematology 2004 76 310 311
10. de Montalembert M Beauvais P Bachir D Galacteros F Girot R Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease European Journal of Pediatrics 1993 152 201 204
11. Miller ST Sleeper LA Pegelow CH Enos LE Wang WC Weiner SJ et al. Prediction of adverse outcomes in children with sickle cell disease New England Journal of Medicine 2000 342 83 89
12. Collet D Modelling Survival Data in Medical Research London Chapman & Hall 1994
13. Cox DR Regression models and life tables Journal of the Royal Statistical Society 1972 34 187 202
14. Platt OS Thorington BD Brambilla DJ Milner PF Rosse WF Vichinsky E et al. Pain in sickle cell disease. Rates and risk factors [see comments] New England Journal of Medicine 1991 325 11 16
15. Gill FM Sleeper LA Weiner SJ Brown AK Bellevue R Grover R et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease Blood 1995 86 776 783
16. Powars D Wilson B Imbus C Pegelow C Allen J The natural history of stroke in sickle cell disease American Journal of Medicine 1978 65 461 471
17. Quinn CT Rogers ZR Buchanan GR Survival of children with sickle cell disease Blood 2004 103 4023 4027
18. Ohene-Frempong K Weiner SJ Sleeper LA Miller ST Embury S Moohr JW et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors Blood 1998 91 288 294
19. Miller ST Macklin EA Pegelow CH Kinney TR Sleeper LA Bello JA et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease Journal of Pediatrics 2001 139 385 390
20. Balkaran B Char G Morris JS Thomas PW Serjeant BE Serjeant GR Stroke in a cohort of patients with homozygous sickle cell disease Journal of Pediatrics 1992 120 360 366
21. Vichinsky EP Neumayr LD Earles AN Williams R Lennette ET Dean D et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group [see comments] New England Journal of Medicine 2000 342 1855 1865
22. Leikin SL Gallagher D Kinney TR Sloane D Klug P Rida W Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease Pediatrics 1989 84 500 508
23. Bainbridge R Higgs DR Maude GH Serjeant GR Clinical presentation of homozygous sickle cell disease Journal of Pediatrics 1985 106 881 885
24. Tshilolo L Mukendi R Girot R [Sickle cell anemia in the south of Zaire. Study of two series of 251 and 340 patients followed-up 1988-1992] Archives of Pediatrics 1996 3 104 111
25. Serjeant G Serjeant B Bone and joint lesions In Sickle Cell Disease 3rd edn New York Oxford University Press 2001 pp. 250 254
26. Kinney TR Sleeper LA Wang WC Zimmerman RA Pegelow CH Ohene-Frempong K et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease Pediatrics 1999 103 640 645
27. Charache S Terrin ML Moore RD Dover GJ McMahon RP Barton FB et al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea Controlled Clinical Trials 1995 16 432 446
28. Hoppe C Vichinsky E Quirolo K van Warmerdam J Allen K Styles L Use of hydroxyurea in children ages 2-5 years with sickle cell disease Journal of Pediatric Hematology/Oncology 2000 22 330 334